brachytherapy AND prostate AND (hasabstract[text] AND "last 180 days"[EDat] AND "last 180 days"[PDat] AND (Humans[Mesh]) AND (Male[MeSH Terms]))

Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.

Gore JL, Kwan L, Lee SP, Reiter RE, Litwin MS.

J Natl Cancer Inst. 2009 Jun 16;101(12):888-92. Epub 2009 Jun 9.

PMID: 19509365 [PubMed - indexed for MEDLINE]

Evaluation of the dose distribution for prostate implants using various 125I and 103Pd sources.

Meigooni AS, Luerman CM, Sowards KT.

Med Phys. 2009 Apr;36(4):1452-8.

PMID: 19472652 [PubMed - indexed for MEDLINE]

Permanent prostate brachytherapy preplanned technique: The modern Seattle method step-by-step and dosimetric outcomes.

Sylvester JE, Grimm PD, Eulau SM, Takamiya RK, Naidoo D.

Brachytherapy. 2009 Apr-Jun;8(2):197-206.

PMID: 19433321 [PubMed - indexed for MEDLINE]

Morbidity and prostate-specific antigen control of external beam radiation therapy plus low-dose-rate brachytherapy boost for low, intermediate, and high-risk prostate cancer.

Koontz BF, Chino J, Lee WR, Hahn CA, Buckley N, Huang S, Kim J, Reagan R, Joyner R, Anscher MS.

Brachytherapy. 2009 Apr-Jun;8(2):191-6.

PMID: 19433320 [PubMed - indexed for MEDLINE]

A 64-year-old man with low-risk prostate cancer: review of prostate cancer treatment.

Sanda MG, Kaplan ID.

JAMA. 2009 May 27;301(20):2141-51. Epub 2009 May 5.

PMID: 19417179 [PubMed - indexed for MEDLINE]

High dose rate radiation treatment of experimental intramuscular prostate carcinoma.

Skourou C, Hoopes PJ, Gibbs-Strauss SL, Gladstone DJ, Strawbridge R, Paulsen KD.

Int J Radiat Biol. 2009 Apr;85(4):330-7.

PMID: 19399678 [PubMed - indexed for MEDLINE]

In vivo dosimetry in the urethra using alanine/ESR during (192)Ir HDR brachytherapy of prostate cancer--a phantom study.

Anton M, Wagner D, Selbach HJ, Hackel T, Hermann RM, Hess CF, Vorwerk H.

Phys Med Biol. 2009 May 7;54(9):2915-31. Epub 2009 Apr 21.

PMID: 19384000 [PubMed - indexed for MEDLINE]

A detailed radiobiological and dosimetric analysis of biochemical outcomes in a case-control study of permanent prostate brachytherapy patients.

Butler WM, Stewart RR, Merrick GS.

Med Phys. 2009 Mar;36(3):776-87.

PMID: 19378738 [PubMed - indexed for MEDLINE]

Effect of percentage of positive prostate biopsy cores on biochemical outcome in low-risk PCa treated with brachytherapy or 3D-CRT.

Pe ML, Trabulsi EJ, Kedika R, Pequignot E, Dicker AP, Gomella LG, Valicenti RK.

Urology. 2009 Jun;73(6):1328-34. Epub 2009 Apr 18.

PMID: 19376564 [PubMed - indexed for MEDLINE]

10:

Ejaculatory function after permanent 125I prostate brachytherapy for localized prostate cancer.

Huyghe E, Delannes M, Wagner F, Delaunay B, Nohra J, Thoulouzan M, Shut-Yee JY, Plante P, Soulie M, Thonneau P, Bachaud JM.

Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):126-32.

PMID: 19362236 [PubMed - indexed for MEDLINE]

11:

Quality of life outcomes following treatment for localized prostate cancer: is there a clear winner?

Parker WR, Montgomery JS, Wood DP Jr.

Curr Opin Urol. 2009 May;19(3):303-8. Review.

PMID: 19300266 [PubMed - indexed for MEDLINE]

12:

What PCPs and geriatricians need to know about robotic prostatectomy and organ-confined prostate cancer.

Carlucci JR, Nabizada-Pace F, Samadi DB.

Geriatrics. 2009 Feb;64(2):8-14. Review.

PMID: 19256581 [PubMed - indexed for MEDLINE]

13:

An increase in medical student knowledge of radiation oncology: a pre-post examination analysis of the oncology education initiative.

Hirsch AE, Mulleady Bishop P, Dad L, Singh D, Slanetz PJ.

Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1003-8; quiz 1008.e1-1008.e2.

PMID: 19251088 [PubMed - indexed for MEDLINE]

14:

Late rectal complications after prostate brachytherapy for localized prostate cancer: incidence and management.

Phan J, Swanson DA, Levy LB, Kudchadker RJ, Bruno TL, Frank SJ.

Cancer. 2009 May 1;115(9):1827-39. Review.

PMID: 19248043 [PubMed - indexed for MEDLINE]

15:

Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapy.

Frank SJ, Levy LB, Kuban DA, Lee AK, Kudchadker RJ, Bruno TL, van Vulpen M, Swanson DA.

J Urol. 2009 Apr;181(4):1658-63; discussion 1663-4. Epub 2009 Feb 23.

PMID: 19233434 [PubMed - indexed for MEDLINE]

16:

Long-term outcomes in younger men following permanent prostate brachytherapy.

Shapiro EY, Rais-Bahrami S, Morgenstern C, Napolitano B, Richstone L, Potters L.

J Urol. 2009 Apr;181(4):1665-71; discussion 1671. Epub 2009 Feb 23.

PMID: 19233394 [PubMed - indexed for MEDLINE]

17:

The effect of obesity on rectal dosimetry after permanent prostate brachytherapy.

Patil N, Crook J, Saibishkumar EP, Aneja M, Borg J, Pond G, Ma C.

Brachytherapy. 2009 Apr-Jun;8(2):218-22. Epub 2009 Feb 20.

PMID: 19230790 [PubMed - indexed for MEDLINE]

18:

Interactive-plan technique conquers the disadvantages of volume-reducing hormone therapy in 125I permanent implantation for localized prostate cancer.

Ishiyama H, Satoh T, Kitano M, Kotani S, Uemae M, Baba S, Hayakawa K.

Int J Clin Oncol. 2009 Feb;14(1):53-5. Epub 2009 Feb 20.

PMID: 19225925 [PubMed - indexed for MEDLINE]

19:

Current status and perspectives of brachytherapy for prostate cancer.

Yoshioka Y.

Int J Clin Oncol. 2009 Feb;14(1):31-6. Epub 2009 Feb 20. Review.

PMID: 19225921 [PubMed - indexed for MEDLINE]

20:

Transperineal injection of hyaluronic acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patients.

Prada PJ, Gonzalez H, Menéndez C, Llaneza A, Fernández J, Santamarta E, Ricarte PP.

Brachytherapy. 2009 Apr-Jun;8(2):210-7. Epub 2009 Feb 12.

PMID: 19213607 [PubMed - indexed for MEDLINE]

Recent Activity